Literature DB >> 10373671

High resolution mapping of chromosome 6 deletions in cervical cancer.

N Mazurenko1, M Attaleb, T Gritsko, L Semjonova, L Pavlova, O Sakharova, F Kisseljov.   

Abstract

Chromosome 6 is frequently affected in different tumors. However, little information exists on chromosome 6 deletions in cervical cancer. We have studied loss of heterozygosity (LOH) and microsatellite instability (MIN) in 62 invasive squamous cell carcinomas of the cervix (CC) using 19 polymorphic microsatellite markers spanning both arms of chromosome 6 and one marker located at 5p15. We found that LOH at chromosome 6 is a common feature of cervical carcinomas: 90% (56/62) of CC had LOH at least at one locus and about 58% (36/62) had LOH on both arms of chromosome 6. The highest LOH incidence was shown in HLA region (6p21.3-6p21.1) with markers D6S273 and D6S276 in 52.7% and 45.2% of informative cases respectively. Frequent LOH on 6q was found at loci D6S311 (6q24-25. 1), D6S305 (6q26) and D6S281 (6q27-6qter) in 37.8%, 33.3% and 39.0% of informative cases respectively. There was no significant correlation observed between clinical parameters of cervical cancer (age, histologic grade, clinical stages and progression) and LOH frequency. Microsatellite instability was found in 3 out of 62 cases (4.8%) at three and more loci out of 20 tested. The study shows that several regions on 6p and 6q may harbour potential tumor-suppressor genes important for cervical cancer progression.

Entities:  

Mesh:

Year:  1999        PMID: 10373671     DOI: 10.3892/or.6.4.859

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  15 in total

1.  PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family.

Authors:  L D Attardi; E E Reczek; C Cosmas; E G Demicco; M E McCurrach; S W Lowe; T Jacks
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

2.  Allelic loss of 6q25-27, the PARKIN tumor suppressor gene locus, in cervical carcinoma.

Authors:  S J Mehdi; M S Alam; S Batra; M M A Rizvi
Journal:  Med Oncol       Date:  2010-07-22       Impact factor: 3.064

3.  Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway.

Authors:  Catherine J Huntoon; Monica D Nye; Liyi Geng; Kevin L Peterson; Karen S Flatten; Paul Haluska; Scott H Kaufmann; Larry M Karnitz
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

4.  Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines.

Authors:  G Piras; A El Kharroubi; S Kozlov; D Escalante-Alcalde; L Hernandez; N G Copeland; D J Gilbert; N A Jenkins; C L Stewart
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 5.  The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway.

Authors:  Noa Furth; Yael Aylon
Journal:  Cell Death Differ       Date:  2017-06-23       Impact factor: 15.828

6.  The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.

Authors:  Monica Cardone; Ayten Kandilci; Cintia Carella; Jonas A Nilsson; Jennifer A Brennan; Sema Sirma; Ugur Ozbek; Kelli Boyd; John L Cleveland; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.

Authors:  Yuri Takahashi; Yasuo Miyoshi; Koji Morimoto; Tetsuya Taguchi; Yasuhiro Tamaki; Shinzaburo Noguchi
Journal:  J Cancer Res Clin Oncol       Date:  2007-02-13       Impact factor: 4.322

8.  Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.

Authors:  L A Koopman; W E Corver; A R van der Slik; M J Giphart; G J Fleuren
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

9.  Decreased expression of LATS1 is correlated with the progression and prognosis of glioma.

Authors:  Tianhai Ji; Dan Liu; Wei Shao; Wensheng Yang; Haiqiao Wu; Xiuwu Bian
Journal:  J Exp Clin Cancer Res       Date:  2012-08-21

10.  Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines.

Authors:  Alfredo Hidalgo; Alberto Monroy; Rosa Ma Arana; Lucía Taja; Guelaguetza Vázquez; Mauricio Salcedo
Journal:  BMC Cancer       Date:  2003-03-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.